Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Walsh

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
NPJ Breast Cancer|March 23, 2021
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancerMaitri Kalra, Yan Tong, David R Jones, et al.
Scientific Reports|January 25, 2023
Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecastsFarah Houdroge, Anna Palmer, Dominic Delport, et al.
Human Genomics|February 8, 2006
Genomic analysis of a heterogeneous Mendelian phenotype: multiple novel alleles for inherited hearing loss in the Palestinian populationTom Walsh, Amal Abu Rayan, Judeh Abu Sa'ed, et al.
Gynecologic Oncology Reports|June 18, 2021
The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancerKate Glennon, Karen Mulligan, Kirsten Carpenter, et al.
Gynecologic Oncology|September 19, 2012
Loss of function germline mutations in RAD51D in women with ovarian carcinomaAnneka Wickramanayake, Anneka Wickramanyake, Greta Bernier, et al.
Hereditary Cancer in Clinical Practice|January 30, 2015
Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancerAna Rafaela de Souza Timoteo, Betina Menezes Albuquerque, Patricia Cristina Pascoto Moura, et al.
Human Molecular Genetics|January 15, 2005
Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish populationAvraham Shaag, Tom Walsh, Paul Renbaum, et al.
JAMA|March 23, 2006
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancerTom Walsh, Silvia Casadei, Kathryn Hale Coats, et al.
Gynecologic Oncology|December 25, 2012
Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testingBarbara M Norquist, Kathryn P Pennington, Kathy J Agnew, et al.
Plos One|March 19, 2015
The potential distribution of invading Helicoverpa armigera in North America: is it just a matter of time?Darren J Kriticos, Noboru Ota, William D Hutchison, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
NPJ Breast Cancer|March 23, 2021
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancerMaitri Kalra, Yan Tong, David R Jones, et al.
Scientific Reports|January 25, 2023
Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecastsFarah Houdroge, Anna Palmer, Dominic Delport, et al.
Human Genomics|February 8, 2006
Genomic analysis of a heterogeneous Mendelian phenotype: multiple novel alleles for inherited hearing loss in the Palestinian populationTom Walsh, Amal Abu Rayan, Judeh Abu Sa'ed, et al.
Gynecologic Oncology Reports|June 18, 2021
The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancerKate Glennon, Karen Mulligan, Kirsten Carpenter, et al.
Gynecologic Oncology|September 19, 2012
Loss of function germline mutations in RAD51D in women with ovarian carcinomaAnneka Wickramanayake, Anneka Wickramanyake, Greta Bernier, et al.
Hereditary Cancer in Clinical Practice|January 30, 2015
Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancerAna Rafaela de Souza Timoteo, Betina Menezes Albuquerque, Patricia Cristina Pascoto Moura, et al.
Human Molecular Genetics|January 15, 2005
Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish populationAvraham Shaag, Tom Walsh, Paul Renbaum, et al.
JAMA|March 23, 2006
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancerTom Walsh, Silvia Casadei, Kathryn Hale Coats, et al.
Gynecologic Oncology|December 25, 2012
Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testingBarbara M Norquist, Kathryn P Pennington, Kathy J Agnew, et al.
Plos One|March 19, 2015
The potential distribution of invading Helicoverpa armigera in North America: is it just a matter of time?Darren J Kriticos, Noboru Ota, William D Hutchison, et al.
Pageof 20